Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
about
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia.Thalidomide for the Treatment of Gastrointestinal Bleeding Due to Angiodysplasia in a Patient with Glanzmann's Thrombasthenia.Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and DiseaseClinical features and treatment of hereditary hemorrhagic telangiectasia
P2860
Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of thalido ...... single-centre, phase 2 study.
@en
type
label
Efficacy and safety of thalido ...... single-centre, phase 2 study.
@en
prefLabel
Efficacy and safety of thalido ...... single-centre, phase 2 study.
@en
P2093
P2860
P50
P1476
Efficacy and safety of thalido ...... single-centre, phase 2 study.
@en
P2093
Carlo L Balduini
Cesare Danesino
Elina Matti
Fabio Pagella
Federica Quaglia
Francesca Bellistri
Marco Benazzo
Pierangela Grignani
Raffaella Bastia
Rosangela Invernizzi
P2860
P304
P356
10.1016/S2352-3026(15)00195-7
P577
2015-10-27T00:00:00Z